Publications

IRIC discoveries have spurred major advances in understanding the development of cancer and opened the way to the creation of new, more targeted therapeutic solutions. Its publications are a reflection of these accomplishments. They also demonstrate the Institute’s drive and productivity.



Homo- and hetero-oligomerization of beta-arrestins in living cells.Storez H, Scott MG, Issafras H, Burtey A, Benmerah A, Muntaner O, Piolot T, Tramier M, Coppey-Moisan M, Bouvier M, Labbé-Jullié C, Marullo SJ. Biol. Chem. 2005-12-02;280(48):40210-5.

Multiplex multidimensional nanoLC-MS system for targeted proteomic analyses.Bonneil E, Tessier S, Carrier A, Thibault PElectrophoresis 2005-12-01;26(24):4575-89.

Identification of unusual bacterial glycosylation by tandem mass spectrometry analyses of intact proteins.Schirm M, Schoenhofen IC, Logan SM, Waldron KC, Thibault PAnal. Chem. 2005-12-01;77(23):7774-82.

The structure and location of SIMP/STT3B account for its prominent imprint on the MHC I immunopeptidome.Caron E, Charbonneau R, Huppé G, Brochu S, Perreault CInt. Immunol. 2005-12-01;17(12):1583-96.

Further evidence that ribavirin interacts with eIF4E.Kentsis A, Volpon L, Topisirovic I, Soll CE, Culjkovic B, Shao L, Borden KLRNA 2005-12-01;11(12):1762-6.

Opposite effects of histone deacetylase inhibitors on glucocorticoid and estrogen signaling in human endometrial Ishikawa cells.Rocha W, Sanchez R, Deschênes J, Auger A, Hébert E, White JH, Mader SMol. Pharmacol. 2005-12-01;68(6):1852-62.

Loss of expression of the Hoxa-9 homeobox gene impairs the proliferation and repopulating ability of hematopoietic stem cells.Lawrence HJ, Christensen J, Fong S, Hu YL, Weissman I, Sauvageau G, Humphries RK, Largman CBlood 2005-12-01;106(12):3988-94.

A new catalog of protein beta-sheets.Parisien M, Major FProteins 2005-11-15;61(3):545-58.

T cells targeted against a single minor histocompatibility antigen can cure solid tumors.Meunier MC, Delisle JS, Bergeron J, Rineau V, Baron C, Perreault CNat. Med. 2005-11-01;11(11):1222-9.

EN2 is a candidate oncogene in human breast cancer.Martin NL, Saba-El-Leil MK, Sadekova S, Meloche S, Sauvageau GOncogene 2005-10-20;24(46):6890-901.

Previous page   |   Next page

Follow IRIC

Logo UdeM